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 Updated the epidemiologic data of Haemophilus parasuis from healthy pigs 20 
in China. 21 
 Serovars distribution was different from previous reports and showed 22 
regional difference. 23 
 Elevated MICs were observed for majority of the tested antimicrobial agents. 24 
 25 
 26 
Abstract 27 
 28 
Haemophilus parasuis is a common colonizer of the upper respiratory tract of 29 
swine and frequently causes disease, especially in weaner pigs. To date, limited 30 
epidemiological data was available for H. parasuis from healthy pigs, which 31 
might be carriers of potential pathogenic strains. In this study, from September 32 
2016 to October 2017, we investigated the prevalence and characteristics of H. 33 
parasuis from healthy pigs in China. Totally, we obtained 244 isolates from 34 
1675 nasal samples from 6 provinces. H. parasuis isolation was more 35 
successful in weaner pigs (22.6%, 192/849), followed by finisher pigs (9.3%, 36 
43/463), and sows (2.5%, 9/363). The most prevalent serovars were 7 (20.1%, 37 
49/244), followed by 3 (14.8%, 36/244), 2 (14.3%, 35/244), 11 (12.7%, 31/244), 38 
5/12 (5.7%, 14/244) and 4 (2.5%, 6/244). Bimodal or multimodal distributions of 39 
MICs were observed for most of the tested drugs, which suggested the 40 
presence of non-wild type populations. It was noted that the MIC90 values of 41 
tilmicosin (64 μg/ml) was relatively higher than that reported in previous studies. 42 
Our results suggest that: 1) potentially pathogenic serovars of H. parasuis are 43 
identified in healthy pigs, and 2) elevated MICs and presence of mechanisms of 44 
resistance not yet described for clinically important antimicrobial agents would 45 
increase the burden of disease caused by H. parasuis. 46 
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Introduction 56 
 57 
Haemophilus parasuis is an important swine pathogen that causes serious 58 
diseases, such as Glässer’s disease, pneumonia and septicemia (Oliveira and 59 
Pijoan, 2004). In the United States, H. parasuis was the leading bacterial health 60 
challenge for nursery pigs (Holtkamp et al., 2007). The Animal and Plant Health 61 
Agency (APHA) reports that the annual incidence of H. parasuis disease shows 62 
a steady increasing trend (except 2012 and 2014) in England, Wales, and 63 
Scotland, from nearly 8% in 2002 to 14% in 2016 (APHA, 2016). H. parasuis is 64 
a common resident organism of the upper respiratory tract of swine and 65 
includes strains with different degree of virulence (Galofré-Milà et al., 2017). 66 
Basically, all piglets are colonized by the bacterium, but only certain types of 67 
strains are capable of causing disease, often following a perturbation to their 68 
host (e.g. co-infections, stress, medication) (Aragon et al., 2012). 69 
Pathogenesis of H. parasuis is a multifactorial process, which is associated with 70 
virulence genes, serovars, biofilm production, etc. Although it is controversial 71 
whether serovar of H. parasuis is an indicator of virulence, serotyping is still an 72 
important feature of Glässer’s disease diagnosis, as it is necessary for 73 
veterinarians and farmers to formulate a vaccination strategy. To date, a total of 74 
15 serovars (serovars 1 through 15) of H. parasuis have been defined using a 75 
gel immuno-diffusion assay as well as molecular serotyping method (the latter 76 
cannot discriminate between serovars 5 and 12) (Howell et al., 2015). Serovars 77 
5 and 4 of H. parasuis are widely considered disease-causing serovars and are 78 
the most common serovars of H. parasuis isolated from clinically sick pigs 79 
worldwide (Oliveira and Pijoan, 2004). On the other hand, serovars 3 and 7 of 80 
H. parasuis are generally recognized as non-virulent, although they can be 81 
isolated from pathological samples and some reports also indicate that isolates 82 
from those serovars can cause disease (Aragon et al., 2010; Zhang et al., 2012; 83 
Costa-Hurtado et al., 2013). The prevalence and distribution of serovars of H. 84 
parasuis isolated from clinical cases has been widely studied but not so from 85 
those isolated from healthy carrier pigs. 86 
In China and many other countries, antimicrobial agents are still largely used 87 
and play an important role for the prevention and treatment of bacterial 88 
diseases. Tilmicosin and florfenicol are the drugs of choice for prevention and 89 
treatment of H. parasuis infections in China. Historically, H. parasuis isolates 90 
showed high susceptibility to frequently used drugs (El Garch et al., 2016; Zhou 91 
et al., 2010), but recently multiple publications indicate a decreased 92 
susceptibility of H. parasuis to several antimicrobial agents from a number of 93 
countries (Brogden et al., 2018; Dayao et al., 2014). In China, the last 94 
nationwide surveillance of antimicrobial susceptibility of H. parasuis was 95 
reported in 2010 (Zhou et al., 2010), which showed that Chinese H. parasuis 96 
isolates were susceptible to most of the antimicrobial agents. However, isolates 97 
from healthy piglets has been shown to carry plasmids with antimicrobial 98 
resistance genes, which may play an important role in the spreading of these 99 
resistances (Moleres et al., 2015). 100 
In order to understand the current situation of H. parasuis from healthy pigs, 101 
here, we investigated the prevalence and characteristics of this organism from 6 102 
provinces in China during 2016–2017. Our findings provide more information for 103 
better understanding of the serovars and antimicrobial resistance distribution in 104 
H. parasuis. 105 
 106 
Materials and methods 107 
 108 
Farms, animals and collection of samples 109 
From September 2016 to October 2017, nasal swabs were collected from 110 
healthy pigs on 13 pig farms and 2 slaughterhouses located in 6 provinces 111 
(Table 1). Samples were collected from different growth stages of pigs: sows, 112 
weaned pigs and finishers. Nasal swabs were placed in tryptic soy broth (TSB) 113 
containing nicotinamide adenine dinucleotide (NAD) (10 μg/ml) and 5% (v/v) 114 
fetal calf serum (FCS), and then transported to the laboratory in a Styrofoam 115 
container with ice packs (within one day). A brief questionnaire was collected 116 
from each farm. The contents of the questionnaire included the type of pig 117 
production, herd size, breeds of pigs, age of piglets and history of antimicrobial 118 
usage. 119 
 120 
Table 1. Source of 244 H. parasuis isolates from healthy pigs 2016–2017. 121 
Province 
Percentage of isolation (No. of nasal samples) 
Total 
Sow Weaner Finisher 
Beijing 1.2% (86) 17.3% (52) 16.7% (60) 10.1% (198) 
Shandong 4.5% (134) 18.3% (153) 8.8% (114) 11.0% (401) 
Henan 2.7% (37) 22.7% (97) – 17.2% (134) 
Shanghai – 31.0% (29) 8.2% (158) 11.8% (187) 
Sichuan 1.5% (68) 12.8% (226) 2.2% (89) 8.4% (383) 
Province 
Percentage of isolation (No. of nasal samples) 
Total 
Sow Weaner Finisher 
Chongqing 0% (38) 32.5% (292) 19.0% (42) 27.7% (372) 
Total 2.5% (363) 22.6% (849) 9.3% (463) 14.6% (1675) 
 122 
 123 
Bacterial isolation and identification 124 
Nasal samples were vortexed vigorously upon arrival at the laboratory. A loopful 125 
of suspension from each sample was streaked onto tryptic soy agar (TSA) 126 
plates containing NAD (10 μg/ml) and 5% (v/v) FCS, and then incubated at 37℃ 127 
for 36 h. One or two suspect colonies from the agar plate were subjected to 128 
further identification by polymerase chain reaction (PCR) as reported previously 129 
(Oliveira et al., 2001). 130 
 131 
DNA preparation and serotyping 132 
The DNA templates for PCR amplification were prepared by boiling. Briefly, 1 ml 133 
of an overnight culture was spinned down at 12,000 × g for 5 min and the 134 
bacterial pellet was resuspended in 100 μl TE buffer (10 mM Tris-HCl, 1 mM 135 
EDTA, pH 8.0). The suspension was heated at 100 °C for 10 min, followed by 136 
cooling on ice for 10 min. After centrifugation at 12,000 × g for 5 min, the 137 
supernatant was transferred to a nucleic acid-free tube and stored at 20 °C. 138 
Serovars of the H. parasuis isolates were determined using a previously 139 
described one-step multiplex PCR (Howell et al., 2015). 140 
 141 
Antimicrobial susceptibility testing 142 
Currently, the recommended method for antimicrobial susceptibility testing of H. 143 
parasuis is not available in the Clinical and Laboratory Standards Institute 144 
(CLSI) guidelines. The minimum inhibitory concentrations (MICs) of H. parasuis 145 
to a panel of antimicrobial agents were determined by the broth microdilution 146 
method (Clinical and Laboratory Standards Institute, 2013) using cation-147 
adjusted Mueller-Hinton broth containing NAD (25 μg/ml) and 1% (v/v) sterile 148 
filtered heat-inactivated chicken serum as suggested by a previous report 149 
(Prüller et al., 2017). Antimicrobial agents and concentrations tested were: 150 
amoxicillin/clavulanic acid (0.06/0.03–64/32 μg/ml), ceftiofur (0.015–16 μg/ml), 151 
enrofloxacin (0.015–16 μg/ml), florfenicol (0.06–64 μg/ml), erythromycin (0.12–152 
128 μg/ml), tilmicosin (0.12–128 μg/ml), doxycycline (0.06–64 μg/ml), and 153 
tetracycline (0.12–128 μg/ml). Escherichia coli ATCC 25922 and 154 
Staphylococcus aureus ATCC 29213 were used as quality control strains. 155 
The MIC50 and MIC90 were defined as the MIC value at which ≥ 50% and ≥ 90% 156 
of the isolates within a test population are inhibited. If the resulting number was 157 
not an integer, the next integer following the respective value represented the 158 
MIC50 and MIC90 (Schwarz et al., 2010). 159 
 160 
Data analysis 161 
The comparison between categorical variables was carried out via χ2 test using 162 
GraphPad prism v7.0. P values lower than 0.05 were considered significant. 163 
 164 
Results 165 
Prevalence of H. parasuis 166 
During the study period, a total of 244 H. parasuis isolates were obtained from 167 
1675 nasal samples (Table 1): 9 isolates from sows, 192 isolates from weaners 168 
and 43 isolates from finishers. The overall isolation rate was 14.6% (244/1675). 169 
Highest prevalence was observed in weaners (22.6%, 192/849), followed by 170 
finishers (9.3%, 43/463) and sows (2.5%, 9/363). 171 
 172 
Serovar distribution 173 
Using the multiplex PCR method, 244 isolates were assigned to 12 serovars, 174 
and 8 isolates were non-typeable. The highest prevalence was observed for 175 
serovar 7 (20.1%, 49/244), followed by serovar 3 (14.8%, 36/244), serovar 2 176 
(14.3%, 35/244), serovar 11 (12.7%, 31/244), serovars 5/12 (5.7%, 14/244) and 177 
serovar 4 (2.5%, 6/244) (Fig. 1). Serovars 14 and 15 were not detected. 178 
 179 
 180 
Fig. 1. Serovar distribution of 244 H. parasuis isolates from healthy pigs by (a) 181 
percentages and (b) number of isolates. NT means non-typeable. 182 
 183 
As shown in Fig. 2, serovars 1 and 3 were detected from samples from all the 6 184 
provinces, while serovar 11 was detected only from Chongqing and Beijing. 185 
Most of the serovar 2 isolates were from Shandong, Shanghai and Beijing. For 186 
serovar 3, most of the isolates were from Sichuan and Chongqing. 187 
 188 
 189 
Fig. 2. Geographic distribution of serovars of 244 H. parasuis isolates from 190 
healthy pigs in 6 provinces of China. The pie chart showed the proportion of the 191 
serovar type in each province. NT means non-typeable. 192 
 193 
Antimicrobial susceptibility profiles 194 
The MIC distribution of 8 antimicrobials for the 244 H. parasuis isolates are 195 
summarized in Table 2. A bimodal or multimodal distribution of MICs was 196 
detected for enrofloxacin, florfenicol, erythromycin, tetracycline, tilmicosin, and 197 
doxycycline. 198 
Table 2. MIC distribution of 244 H. parasuis isolates from healthy pigs 2016–199 
2017. 200 
Antimicrobial agent 
No. of isolates with MIC values (μg/ml) of: 
0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 MIC50 MIC90 
Amoxicillin/Clavulanic 
acida 
  54
* 2 48 47 45 32 12 4 0 0 0 0   0.25 1 
Ceftiofur 126* 2 36 39 13 12 8 4 4 0 0 0     <0.015 0.25 
Enrofloxacin 40* 3 26 29 14 18 29 49 27 5 3 1     0.25 2 
Florfenicol    0 5 66 140 15 1 0 0 11 6 0   0.5 1 
Erythromycin    2* 0 3 11 77 77 28 18 18 6 0 2 2* 2 16 
Tilmicosin    1* 1 5 23 47 21 27 17 21 33 29 18 1* 4 64 
Doxycycline   5
* 2 19 76 38 45 25 13 18 3 0 0   0.5 4 
Tetracycline    4* 4 23 59 67 10 7 26 25 19 0 0  1 16 
a 201 
Concentrations for amoxicillin given, tested with clavulanic acid in a concentration ratio 2:1. 202 
* 203 
Number of isolates with MIC values equal to or higher/lower than concentrations of the test 204 
range. The white areas represent the tested range of an antimicrobial agent. 205 
 206 
The MIC50 and MIC90 values for H. parasuis were also calculated (Table 2). For 207 
antimicrobial agents most frequently used in preventing and treating diseases 208 
caused by H. parasuis (e.g. tilmicosin and florfenicol), elevated MICs were 209 
observed compared to that from previous reports (Zhou et al., 2010). For 210 
antimicrobial agents less frequently used for the treatment of H. parasuis 211 
infections, the MIC90 and MIC50 values were relatively low. For example, MIC50 212 
and MIC90 values of ceftiofur were 0.015 μg/ml and 0.25 μg/ml, respectively. 213 
 214 
Discussion 215 
H. parasuis is one of the most important pathogens in pigs. Certain serovars of 216 
this organism are clearly associated with clinical infections. In this study, we 217 
obtained 244 H. parasuis isolates from 1675 nasal samples from healthy pigs 218 
across 6 provinces. We also characterized the serovars and antimicrobial 219 
susceptibility of the H. parasuis isolates. Our result indicated the high 220 
prevalence and increased antimicrobial resistance of H. parasuis from healthy 221 
pigs. In addition, pathogenic serovars were observed in these isolates. 222 
The overall prevalence by culture (14.6%) of H. parasuis among healthy pigs in 223 
this study was slightly lower than that found in diseased pigs (22.1%) in a 224 
previous report (Cai et al., 2005), but this discordance can be explained by the 225 
differences between both studies. Cai et al. (2005) included isolates collected 226 
from lesions of diseased pigs, which more probably were weaned pigs, while in 227 
our study, samples were obtained from the nasal cavities of healthy sows, 228 
weaners and finishers. Our results confirm that the prevalence of H. parasuis in 229 
weaned pigs was significantly higher than in finisher pigs (22.6% vs 9.3%, P < 230 
0.0001) and sows (22.6% vs 2.5%, P < 0.0001), as previously reported (Angen 231 
et al., 2007; Cerdà-Cuéllar et al., 2010). Moreover, even in weaned pigs, the 232 
isolation rate varied between different farms, ranging from 0% to 51.6% (data 233 
not shown). The phenomenon was also observed in previous reports (MacInnes 234 
et al., 2008; Turni and Blackall, 2010). 235 
Serovars 7, 3, 2, and 11 were the most prevalent serovars (all above 10%), 236 
which are largely different from previous reports with clinical isolates, where 237 
serovars 5 and 4 were the predominant serovars (Angen et al., 2004; Cai et al., 238 
2005; Castilla et al., 2012; Ma et al., 2016). The difference is probably due to 239 
the sampling sites: all the nasal samples in this study were collected from 240 
healthy pig herds, and in other studies the samples were lungs, fluids from 241 
joints, etc. which were obtained from sick pigs. Serovars 7, 3, and 11 were used 242 
to be considered as avirulent, and serovar 2 as moderate virulent according to 243 
challenge experiment using a small number of isolates (Aragon et al., 2010; 244 
Kielstein and Rapp-Gabrielson, 1992). In fact, serovars 3 and 11 isolates were 245 
also reported virulent or even highly virulent (Aragon et al., 2010; Dai et al., 246 
2016). Serovars 5 and 4 isolates are widely considered disease-causing strains, 247 
and they were most commonly isolated from sick pigs with Glässer’s disease 248 
(Howell et al., 2014; Tadjine et al., 2004). In the present study, serovars 5/12 249 
and 4 were detected in a low percentage (5.7% and 2.5% for 5/12 and 4, 250 
respectively). However, this low isolation of serovars 5/12 and 4 in healthy 251 
herds can be potentially significant because these isolates may epidemically 252 
spread under certain circumstances. It was mentioned that 93.5% (29/31) of 253 
serovar 11 H. parasuis were isolated from Chongqing province, which showed 254 
an obvious regional difference. 255 
MICs distribution is one of the most important parameters for reporting results of 256 
antimicrobial susceptibility testing (Schwarz et al., 2010). If the MICs distribution 257 
is bimodal or multimodal, it usually indicates the presence of resistance 258 
mechanism/s (Morrissey et al., 2014). The MICs of most of the antibiotics in our 259 
study showed bimodal or multimodal distributions (enrofloxacin, florfenicol, 260 
erythromycin, tetracycline, tilmicosin, and doxycycline). For example, florfenicol 261 
MICs showed a bimodal distribution, and isolates with MICs > 4 μg/ml 262 
(distributed around the second peak) were proved to harbor the phenicol 263 
resistance gene floR (data not published). It was noteworthy that known 264 
macrolide resistance mechanisms cannot completely account for the multimodal 265 
distribution of tilmicosin MICs (data not published), which might imply a new 266 
tilmicosin resistance mechanism. This was of great concern, as nasal isolates 267 
were considered as an important reservoir for antimicrobial resistance. Bimodal 268 
or multimodal distributions of tilmicosin MICs were also reported in Germany 269 
and Australia recently (Brogden et al., 2018; Dayao et al., 2014, 2016). 270 
For most of the tested antimicrobials, elevated MICs were observed compared 271 
to previous reports. For example, tilmicosin MIC90 values were 64 μg/ml in our 272 
study, which are 16-fold higher than that in Germany (Brogden et al., 2018) and 273 
32-fold higher than previously described in China (Zhou et al., 2010). Florfenicol 274 
MIC90 values (1 μg/ml) were similar to those in Germany (0.5 μg/ml) and China 275 
in 2010 (1 μg/ml). However, no isolates had MICs > 1 μg/ml in the two 276 
previously reported studies, while in our study, 7% (17/244) of the isolates had 277 
MICs > 8 μg/ml. 278 
 279 
Conclusions 280 
In conclusion, serovar distribution was different from previous reports with 281 
clinical isolates and showed regional differences. Elevated MICs of H. parasuis 282 
for most of the antimicrobial agents were possibly due to the spread of multiple 283 
resistance mechanisms by the selection of antibiotics, especially for those 284 
frequently used for preventing and treating diseases caused by this genus, 285 
which highlighted the importance of using antimicrobials more prudently. All 286 
these findings provide us an overview of current epidemiological status of H. 287 
parasuis and can be helpful for the prevention and understanding of the disease 288 
caused by this bacterium. 289 
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